Filing Details
- Accession Number:
- 0001181431-13-039210
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-07-08 19:04:30
- Reporting Period:
- 2013-07-02
- Filing Date:
- 2013-07-08
- Accepted Time:
- 2013-07-08 19:04:30
- Original Submission Date:
- 2013-07-05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1509190 | Aratana Therapeutics Inc. | PETX | Pharmaceutical Preparations (2834) | 383826477 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1493612 | Avalon Ventures Ix, L.p. | 1134 Kline Street La Jolla CA 92037 | No | No | Yes | No | |
| 1578781 | Avalon Ventures Ix Gp, Llc | 1134 Kline Street La Jolla CA 92037 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-02 | 2,406,739 | $0.00 | 2,642,668 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-07-02 | 802,246 | $0.00 | 3,444,914 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-07-02 | 225,631 | $0.00 | 3,670,545 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-07-02 | 500,000 | $6.00 | 4,170,545 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2013-07-02 | 4,000,000 | $0.00 | 2,406,739 | $1.66 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2013-07-02 | 1,333,333 | $0.00 | 802,246 | $4.99 |
| Common Stock | Series C Convertible Perferred Stock | Disposition | 2013-07-02 | 375,000 | $0.00 | 225,631 | $6.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.6016847 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date.
- Immediately prior to the closing of the Issuer's initial public offering, the Issuer issued 235,929 shares of its Common Stock to the holders of its Series A, B and C Preferred Stock in satisfaction of accumulated and unpaid dividends.
- Immediately.
- Not applicable.
Billionaire Hedge Funds
